GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sigma Healthcare Ltd (OTCPK:SIGGF) » Definitions » Cash Flow from Financing

Sigma Healthcare (Sigma Healthcare) Cash Flow from Financing : $196 Mil (TTM As of Jan. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sigma Healthcare Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Jan. 2024, Sigma Healthcare received $262 Mil more from issuing new shares than it paid to buy back shares. It received $0 Mil from issuing more debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $3 Mil paying cash dividends to shareholders. It spent $54 Mil on other financial activities. In all, Sigma Healthcare earned $205 Mil on financial activities for the six months ended in Jan. 2024.


Sigma Healthcare Cash Flow from Financing Historical Data

The historical data trend for Sigma Healthcare's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sigma Healthcare Cash Flow from Financing Chart

Sigma Healthcare Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -68.88 -205.34 92.53 -81.32 196.30

Sigma Healthcare Semi-Annual Data
Jul14 Jan15 Jul15 Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 76.53 -61.19 -19.24 -8.70 204.86

Sigma Healthcare Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Sigma Healthcare's Cash from Financing for the fiscal year that ended in Jan. 2024 is calculated as:

Sigma Healthcare's Cash from Financing for the quarter that ended in Jan. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Jan. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $196 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sigma Healthcare  (OTCPK:SIGGF) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Sigma Healthcare's issuance of stock for the six months ended in Jan. 2024 was $262 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Sigma Healthcare's repurchase of stock for the six months ended in Jan. 2024 was $0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Sigma Healthcare's net issuance of debt for the six months ended in Jan. 2024 was $0 Mil. Sigma Healthcare received $0 Mil from issuing more debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Sigma Healthcare's net issuance of preferred for the six months ended in Jan. 2024 was $0 Mil. Sigma Healthcare paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Sigma Healthcare's cash flow for dividends for the six months ended in Jan. 2024 was $-3 Mil. Sigma Healthcare spent $3 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Sigma Healthcare's other financing for the six months ended in Jan. 2024 was $-54 Mil. Sigma Healthcare spent $54 Mil on other financial activities.


Sigma Healthcare Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Sigma Healthcare's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Sigma Healthcare (Sigma Healthcare) Business Description

Traded in Other Exchanges
Address
2125 Dandenong Road, Level 6, Clayton, Melbourne, VIC, AUS, 3168
Sigma Healthcare is an Australian pharmaceutical distributor, wholesaler and pharmacy franchisor. The revenue growth prospects and returns of pharmaceutical distribution are subdued due to ongoing Pharmaceutical Benefits Scheme, or PBS, price reform, and regulated wholesale gross margins being capped at 7% for community pharmacy. As a result, Sigma and its competitors are seeking to expand into unregulated revenue streams. In addition, pharmacy ownership is restricted to pharmacists, thereby excluding direct corporate ownership and requiring exposure via a franchise business model.